Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
CryoCell International Inc
CCELCurrent price
8.33 USD
+0.9 USD (+12.14%)
Last closed
7.46 USD
Company
www.cryo-cell.com
ISIN
US2288951088
Sector
Healthcare
Industry
Medical Care Facilities
Exchange
NYSE
Capitalization
59 418 120 USD
Yield for 12 month
+63.05 %
1Y
3Y
5Y
10Y
15Y
CCEL
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida. Address: 700 Brooker Creek Boulevard, Oldsmar, FL, United States, 34677
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9 USDP/E ratio
–Dividend Yield
–Current Year
+31 343 695 USD
Last Year
+30 336 749 USD
Current Quarter
+8 066 715 USD
Last Quarter
+8 042 811 USD
Current Year
+22 901 385 USD
Last Year
+21 544 391 USD
Current Quarter
+5 940 869 USD
Last Quarter
+6 018 061 USD
Key Figures CCEL
1 year
3 years
5 years
10 years
EBITDA
641 301 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-0.13 %
PEG Ratio
–
Return On Equity TTM
129.2 %
Wall Street Target Price
9 USD
Revenue TTM
31 838 476 USD
Book Value
-1.19 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2.5 %
Dividend Yield
–
Gross Profit TTM
21 544 391 USD
Earnings per share
-1.1 USD
Diluted Eps TTM
-1.1 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
62.5 %
Profit Margin
-28.04 %
Dividend Analytics CCEL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
276 %Dividend History CCEL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
15.11.2024
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
29.11.2024
Stock Valuation CCEL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
2.1274
Price Sales TTM
1.8662
Enterprise Value EBITDA
-6.6873
Price Book MRQ
9.7236
Financials CCEL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CCEL
For 52 weeks
3.67 USD
9.5 USD
50 Day MA
6.41 USD
Shares Short Prior Month
9 397
200 Day MA
6.95 USD
Short Ratio
2.5
Shares Short
9 453
Short Percent
0.16 %
BeatStart